Treatment Efficacy and Prognostic Factors for Huge HCC Based on Barcelona Clinic Liver Cancer Staging |
Zhang, Zhi-Ming
(Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University)
Zhang, Yu-Mei (Department of Chemotherapy, The Affiliated Tumor Hospital of Guangxi Medical University) Gao, Sheng (Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University) Yuan, Wei-Ping (Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University) Zhao, Yin-Nong (Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University) Xiang, Bang-De (Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University) Wu, Fei-Xiang (Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University) Wu, Guo-Bin (Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University) Liu, Jian-Yong (Department of Hepatobiliary Surgery, The Affiliated Tumor Hospital of Guangxi Medical University) |
1 | Cheng XP, Zhang ZW (2009). Surgical treatment strategy of large and huge hepatocellular carcinoma. Chin J Operative Proced General Surg, 3, 702-6. |
2 | Jin YJ, Lee JW, Choi YJ, et al (2014). Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A. J Gastrointest Surg, 18, 555-61. DOI |
3 | Chow KC, Tang CN, Lai EC, et al (2013). Curative treatment for recurrent tumour implantation after ruptured hepatocellular carcinoma. Hong Kong Med J, 19, 82-4. |
4 | Graf D, Vallbohmer D, Knoefel WT, et al (2014). Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med, 25, 430-7. DOI ScienceOn |
5 | Hironori K, Masaru T, Yuichiro O, et al (2008). Laparoscopyassisted hepatectomy for giant hepatocellular carcinoma. Surg Laparosc Endosc Percutan Tech, 18, 127-31. DOI ScienceOn |
6 | Joshita S, Yoshizawa K, Sano K, et al (2010). A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome. Intern Med, 49, 991-4. DOI |
7 | Li GH, Hong ZX, Zhang KM (2012). Surgical treatment of huge hepatocellular carcinoma. J Mod Oncol, 20, 1495- 7. |
8 | Li SH, Guo ZX, Xiao CZ, et al (2013). Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection. Asian Pac J Cancer Prev, 14, 4759-63. 과학기술학회마을 DOI ScienceOn |
9 | Li SL, Su M, Peng T, et al (2013). Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 14, 217-23. 과학기술학회마을 DOI ScienceOn |
10 | Arai T, Akita S, Sakon M, et al (2014). Hepatocellular carcinoma associated with sarcoidosis. Int J Surg Case Rep, 5, 562-5. DOI ScienceOn |
11 | Ren YQ, Han JQ, Cao JB, et al (2012). Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population. Asian Pac J Cancer Prev, 13, 5451-4. 과학기술학회마을 DOI ScienceOn |
12 | Bagi CM, Gebhard DF, Andresen CJ (2012). Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models ofhepatocellular carcinoma. Eur J Gastroenterol Hepatol, 24, 563-74. DOI |
13 | Maida M, Orlando E, Camma C, et al (2014). Staging systems of hepatocellular carcinoma: areviewofliterature. World J Gastroenterol, 20, 4141-50. DOI ScienceOn |
14 | Que JY, Lin LC, Lin KL, et al (2014). The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities. Radiat Oncol, 9, 120. DOI ScienceOn |
15 | Scaggiante B, Kazemi M, Pozzato G, et al (2014). Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol, 20, 1268-88. DOI ScienceOn |
16 | Shin YJ, Kim MS, Yoo SY, et al (2010). Pilot study of stereotactic body radiotherapy for huge hepatocellular carcinoma unsuitable for other therapies. Tumori, 96, 65-70. |
17 | Tsoulfas G, Mekras A, Agorastou P, et al (2012). Surgical treatment for large hepatocellular carcinoma: does size matter? ANZ J Surg, 82, 510-7. DOI ScienceOn |
18 | Yang L, Xu J, Ou D, et al (2013). Hepatectomy for Huge Hepatocellular Carcinoma: Single Institutes Experience. World J Surg, 37, 2189-96. DOI ScienceOn |
19 | Wang ZJ, Wang MQ, Duan F, et al (2013). Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 1649-54. 과학기술학회마을 DOI ScienceOn |
20 |
Yang J, Li C, Wen TF, et al (2014). Is hepatectomy for huge hepatocellular carcinoma ( |
21 | Yang LY, Fang F, Yang H (2010). Surgical resection of solitary huge hepatocellular carcinoma. Chin J Pract Surg, 30, 662-4. |
22 |
Yamashita Y, Taketomi A, Shirabe K, et al (2011). Outcomes of hepatic resection for huge hepatocellularcarcinoma ( |
23 | Zhang Y, Zhang WL, Huang DS, et al (2013). Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study. Asian Pac J Cancer Prev, 14, 4583-9. 과학기술학회마을 DOI ScienceOn |
24 |
Zhong NB, Lv GM, Chen ZH (2014). Stereotactic body radiotherapy combined with transarterial chemoembolization for huge ( |
25 | Zhang ZW, Cheng XP (2008). Techniques for large hepatic resection. J Hepatobil Surg, 16, 6-7. |
![]() |